SCHEMBL15025136

SCHEMBL15025136

CC(=O)Nc1nc2c(s1)CCN(N)CC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 6/20 0.51
TSHR P16473 2/20 0.48
OGA O60502 1/20 0.45
HSD17B10 Q99714 3/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
GAA P10253 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 2/20 0.42
GRM5 P41594 1/20 0.41
PKM P14618 2/20 0.40
MAPT P10636 1/20 0.40
NFKB1 P19838 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15011715 0.84 PIK3CG (0.50) PIK3CGTSHROGAHSD17B10NPC1
SCHEMBL659214 0.80 TSHR (0.71) TSHRHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL13035816 0.80 TSHR (0.67) TSHRHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL12334407 0.78 PIK3CG (0.56) PIK3CGTSHROGANPC1RAB9A
SCHEMBL14991240 0.78 GRAMD1A (0.55) PIK3CGTSHR
SCHEMBL23475155 0.76 OGA (0.50) PIK3CGTSHROGAHSD17B10NPC1
SCHEMBL21146542 0.76 GAA (0.69) PIK3CGOGANPC1RAB9ASMN1; SMN2
SCHEMBL21146020 0.76 OGA (0.61) PIK3CGOGANPC1RAB9ASMN1; SMN2
SCHEMBL17613205 0.76 ALDH1A1 (0.45) PIK3CGTSHRNPC1RAB9ASMN1; SMN2
SCHEMBL7292357 0.76 ALDH1A1 (0.67) PIK3CGOGANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788333-B1 1,2,4-TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INT (DE) 2016-03-23 EP disclosed
WO-2013083741-A1 1,2,4 -TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 WO disclosed